(Q39549761)

13 September 2017

Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon (English)

1 reference

13 September 2017

0 references

Hayoz D

1

1 reference

13 September 2017

Bizzini G

2

1 reference

13 September 2017

Noël B

3

1 reference

13 September 2017

Depairon M

4

1 reference

13 September 2017

Burnier M

5

1 reference

13 September 2017

Fauveau C

6

1 reference

13 September 2017

Rouillon A

7

1 reference

13 September 2017

Brouard R

8

1 reference

13 September 2017

Brunner HR

9

1 reference

13 September 2017

1 October 2000

1 reference

13 September 2017

1 reference

13 September 2017

39

1 reference

13 September 2017

10

1 reference

13 September 2017

1132-1138

1 reference

Role of digital artery adrenoceptors in Raynaud's disease

13 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Cutaneous responses to endothelin-1 and histamine in patients with vibration white finger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Digital cutaneous vascular responses to histamine and neuropeptides in Raynaud's phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

On the nature of Raynaud's phenomenon: the role of histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Pharmacotherapy of Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Heterogeneity of the aggregation response of human platelets to arginine vasopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Different factors influencing the expression of Raynaud's phenomenon in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Biphasic forearm vascular responses to intraarterial arginine vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

Arginine vasopressin attenuates phenylephrine-induced forearm vasoconstriction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1132

10.1093/RHEUMATOLOGY/39.10.1132

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference